MYGN

#2963
Myriad Genetics Inc
5.1900 USD
+5.70%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
5.1900
5.1900
Faixa anual
4.1050
8.5000
Mudança diária
+5.70%
Mudança mensal
+13.07%
Mudança em 6 meses
-37.24%
Mudança anual
-37.24%
Fechamento anterior
4.9100
Abrir
5.1900
Bid
Ask
Mínimo
5.1900
High
5.1900
Volume
102
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 485.3074 M
  • Employee 2 700
  • Founded 1991
  • CEO Paul J. DiazPaul J. Diaz
  • Website www.myriad.com
  • Headquarter Delaware, United States
  • FIGI BBG000D9H9F1
  • Industry Diagnósticos e pesquisa
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-1.56
Índice preço/fluxo de caixa
0.69

Myriad Genetics Inc

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity.

Notícias